These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

287 related articles for article (PubMed ID: 7478125)

  • 1. Pre-transplant hypertension: a major risk factor for chronic progressive renal allograft dysfunction?
    Frei U; Schindler R; Wieters D; Grouven U; Brunkhorst R; Koch KM
    Nephrol Dial Transplant; 1995; 10(7):1206-11. PubMed ID: 7478125
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Risk factors of long-term graft loss in renal transplant recipients with chronic allograft dysfunction.
    Khalkhali HR; Ghafari A; Hajizadeh E; Kazemnejad A
    Exp Clin Transplant; 2010 Dec; 8(4):277-82. PubMed ID: 21143092
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Factors influencing renal function after liver transplantation. Results from the MOST, an international observational study.
    Burra P; Senzolo M; Masier A; Prestele H; Jones R; Samuel D; Villamil F
    Dig Liver Dis; 2009 May; 41(5):350-6. PubMed ID: 19046932
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A multi-factor analysis of kidney regraft outcomes.
    Gjertson DW
    Clin Transpl; 2002; ():335-49. PubMed ID: 12971460
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Early acute rejection does not affect chronic allograft nephropathy and death censored graft failure.
    He X; Johnston A
    Transplant Proc; 2004 Dec; 36(10):2993-6. PubMed ID: 15686679
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Completely reversed acute rejection episodes do not influence the long-term renal allograft survival].
    Wu JY; Chen JH; Wang YM; Zhang JG; Zhu C; Wang SY; Zhang P; Huang HF; He Q
    Zhonghua Yi Xue Za Zhi; 2003 Jan; 83(2):106-9. PubMed ID: 12812676
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Changing profiles of proteinuria in renal transplantation. Predictive factors for its appearance].
    Jiménez del Cerro LA; Franco A; Olivares J
    Nefrologia; 2002; 22(4):356-63. PubMed ID: 12369127
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The UNOS renal transplant registry.
    Cecka JM
    Clin Transpl; 2001; ():1-18. PubMed ID: 12211771
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Major effects of delayed graft function and cold ischaemia time on renal allograft survival.
    Quiroga I; McShane P; Koo DD; Gray D; Friend PJ; Fuggle S; Darby C
    Nephrol Dial Transplant; 2006 Jun; 21(6):1689-96. PubMed ID: 16490743
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The impact of gender and age matching for long-term graft survival in living donor renal transplantation.
    Kwon OJ; Kwak JY; Kang CM
    Transplant Proc; 2005 Mar; 37(2):726-8. PubMed ID: 15848514
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Changes in renal function in renal transplantation. Predictive factors for functional deterioration].
    Jiménez del Cerro LA; Franco A; Rivera F; Olivares J
    Nefrologia; 2001; 21(3):295-304. PubMed ID: 11471310
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pre-transplant risk factors for renal allograft dysfunction at one year in Indian patients.
    Prabhu R; John GT; Shankar V; Thomas PP; Abi Abraham M; Jeyaseelan L; Jacob CK
    Natl Med J India; 2001; 14(1):18-21. PubMed ID: 11242692
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sirolimus-based triple immunosupression with antithymocyte globulin induction in expanded criteria donor kidney transplantation.
    Uslu A; Nart A; Taşli FA; Postaci H; Aykas A; Doğan M; Sahin T
    Nephrology (Carlton); 2008 Feb; 13(1):80-6. PubMed ID: 18199109
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The LifeLink Foundation and cadaver kidney transplantation in Tampa.
    LeFor WM; Wright CE; Bowers VD; Heinrichs DF; Shires DL
    Clin Transpl; 1999; ():149-58. PubMed ID: 11038633
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of human leukocyte antigen matching and recipients' panel reactive antibodies on two-year outcome in presensitized renal allograft recipients.
    Meng HL; Jin XB; Li XT; Wang HW; Lü JJ
    Chin Med J (Engl); 2009 Feb; 122(4):420-6. PubMed ID: 19302748
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of parathyroidectomy on renal graft function, blood pressure and serum lipids in kidney transplant recipients: a single centre study.
    Evenepoel P; Claes K; Kuypers D; Maes B; Vanrenterghem Y
    Nephrol Dial Transplant; 2005 Aug; 20(8):1714-20. PubMed ID: 15919696
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Risk factors of chronic rejection in kidney transplantation, results of a single center study].
    Delmas S; Picot MC; Vergnes C; Cristol JP; Mourad G
    Nephrologie; 1999; 20(3):153-8. PubMed ID: 10418005
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Kidney transplantation, the Halifax experience.
    Belitsky P; MacDonald AS; Lawen J; McAlister V; Bitter-Suermann H; Kiberd B; West K; Sketris I
    Clin Transpl; 1996; ():231-40. PubMed ID: 9286572
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effect of race and ethnicity on kidney allograft outcome.
    Katznelson S; Gjertson DW; Cecka JM
    Clin Transpl; 1995; ():379-94. PubMed ID: 8794281
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chronic kidney disease in renal transplant recipients.
    Marcén R; Pascual J; Tenorio M; Ocaña EJ; Teruel JL; Villafruela JJ; Fernández M; Burgos FJ; Ortuño J
    Transplant Proc; 2005 Nov; 37(9):3718-20. PubMed ID: 16386516
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.